Title |
Challenges and future prospects of antibiotic therapy: from peptides to phages utilization
|
---|---|
Published in |
Frontiers in Pharmacology, May 2014
|
DOI | 10.3389/fphar.2014.00105 |
Pubmed ID | |
Authors |
Santi M. Mandal, Anupam Roy, Ananta K. Ghosh, Tapas K. Hazra, Amit Basak, Octavio L. Franco |
Abstract |
Bacterial infections are raising serious concern across the globe. The effectiveness of conventional antibiotics is decreasing due to global emergence of multi-drug-resistant (MDR) bacterial pathogens. This process seems to be primarily caused by an indiscriminate and inappropriate use of antibiotics in non-infected patients and in the food industry. New classes of antibiotics with different actions against MDR pathogens need to be developed urgently. In this context, this review focuses on several ways and future directions to search for the next generation of safe and effective antibiotics compounds including antimicrobial peptides, phage therapy, phytochemicals, metalloantibiotics, lipopolysaccharide, and efflux pump inhibitors to control the infections caused by MDR pathogens. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | <1% |
Sweden | 1 | <1% |
Unknown | 266 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 46 | 17% |
Student > Bachelor | 45 | 17% |
Student > Master | 30 | 11% |
Researcher | 26 | 10% |
Student > Postgraduate | 12 | 4% |
Other | 41 | 15% |
Unknown | 68 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 46 | 17% |
Agricultural and Biological Sciences | 46 | 17% |
Medicine and Dentistry | 20 | 7% |
Immunology and Microbiology | 17 | 6% |
Chemistry | 17 | 6% |
Other | 42 | 16% |
Unknown | 80 | 30% |